Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Sign Up to like & getrecommendations! Published in 2017 at "Biomarker Research"
DOI: 10.1186/s40364-017-0093-8
Abstract: We have seen a notable increase in the application of PD-1/PD-L1 inhibitors for the treatment of several solid and hematogenous malignancies including metastatic melanoma, non-small-cell lung cancer and lymphoma to name a few. The need… read more here.
Keywords: utility immunohistochemistry; response; utility; assays predicting ... See more keywords
Evaluation of utility of immunohistochemistry markers as a tool for objective diagnosis of low-grade myelodysplastic syndrome in routine reporting: Prospective observational study
Sign Up to like & getrecommendations! Published in 2022 at "Indian Journal of Pathology and Microbiology"
DOI: 10.4103/ijpm.ijpm_18_21
Abstract: Purpose: Diagnosis of myelodysplastic syndrome (MDS) primarily relies on the detection of morphological dysplasia in bone marrow. It is subjective and many studies have reported lack of interobserver agreement in reporting. Biopsy is preferred specimen… read more here.
Keywords: mds; utility immunohistochemistry; diagnosis; ihc ... See more keywords